Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)
14 May 2022 - 6:34AM
Edgar (US Regulatory)
Filed by Biotech Acquisition Company
pursuant to Rule 425 under the U.S. Securities
Act of 1933, as amended,
under the Securities Exchange Act of 1934, as
amended
Subject Company: Biotech Acquisition Company
Commission File No.: 001-39935
Date: May 13, 2022
|
a. |
Open Letter to the Respiratory Community |
On May 13, 2022, Blade Therapeutics, Inc. (“Blade”)
– which is a party to a previously disclosed Agreement and Plan of Merger, dated as of November 8, 2021, with Biotech Acquisition
Company (“BAC”), among other parties – posted an open letter to the respiratory community from Wendye Robbins, the President
and CEO of Blade, on Blade’s website at: https://www.blademed.com/news/May-13-2022/.
On May 13, 2022, Blade shared the following on its LinkedIn page:
The Blade team welcomes the American Thoracic Society 2022 International
Conference to the San Francisco Bay Area that we call “home.” Read Blade CEO Wendye Robbins’ open letter to the respiratory
community as we start #ats2022 - click here: https://lnkd.in/gKCAyRpe
Hashtags: #lungfibrosis #ifp #fibrosis #clinicalresearch
#clinicaldevelopment
Wendye Robbins Jean-Frederic Viret Joel Outten
Bassem Elmankabadi, M.D. Tina Rarick Daven Mody Jack Lin Walter Yu Prabha N. Ibrahim Ravi Rajagopalan Xiang Xu Minji Kim Jin-Xing Huang
Michael Blash marianne eid Denise San Bartolome
Haiyang Hu (CA, CPA Illinois, California) Jong
Seok Kang Krishna Gorti, M.D., FRCS Minji Kim Nikhil Aneja Weiqun Liu, MD MPH
American Thoracic Society
IMPORTANT LEGAL INFORMATION
The foregoing information and statements contained
in this Rule 425 filing are qualified in their entirety by the disclaimers set forth on the Form 8-K filed by Biotech Acquisition Company
with the SEC on November 8, 2021.
Biotech Acquisition (NASDAQ:BIOTU)
Historical Stock Chart
From Aug 2024 to Oct 2024
Biotech Acquisition (NASDAQ:BIOTU)
Historical Stock Chart
From Oct 2023 to Oct 2024